X4 Pharmaceuticals IncXFOR
Price$2.90

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $9M-90.6% YoYTTM through 31 Mar 2026
Net Income -$99.7MTTM through 31 Mar 2026

Margins

Current
Gross Margin77.9%
Operating Margin-749.9%
Net Margin-745.9%

Returns

-59.2%ROE
-36.9%ROA

Balance Sheet Health

Debt / Equity0.45x
Current Ratio9.05x
Net Debt-$156.6Mnet cash position
Cash & Equivalents$216.9M

Quality Metrics

Earnings-Beat Rate100.0%

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.